AMN HEALTHCARE SERVICES INC (AMN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 2B 4B 6B FY09: 759.8M FY10: 669.9M FY11: 887.5M FY12: 954M FY13: 1B FY14: 1B FY15: 1.5B FY16: 1.9B FY17: 2B FY18: 2.1B FY19: 2.2B FY20: 2.4B FY21: 4B FY22: 5.2B FY23: 3.8B FY24: 3B FY25: 2.7B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 600M 1.2B 1.8B FY09: 204.4M FY10: 184.4M FY11: 249.3M FY12: 270.4M FY13: 297.3M FY14: 316.1M FY15: 469.4M FY16: 619.7M FY17: 644.4M FY18: 696.4M FY19: 743.5M FY20: 791.8M FY21: 1.3B FY22: 1.7B FY23: 1.2B FY24: 919.4M FY25: 774.1M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-250M 0 250M 500M 750M FY09: -153.6M FY10: -43.8M FY11: 37.6M FY12: 53.3M FY13: 65.5M FY14: 67.9M FY15: 128.9M FY16: 191.6M FY17: 212.4M FY18: 202.8M FY19: 176.9M FY20: 149.3M FY21: 478M FY22: 647.1M FY23: 338.4M FY24: -102.7M FY25: -55.5M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-200M 0 200M 400M 600M FY09: -122.2M FY10: -52M FY11: -26.3M FY12: 17.1M FY13: 32.9M FY14: 33.2M FY15: 81.9M FY16: 105.8M FY17: 132.6M FY18: 141.7M FY19: 114M FY20: 70.7M FY21: 327.4M FY22: 444.1M FY23: 210.7M FY24: -147M FY25: -95.7M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 1.5B 3B 4.5B FY09: 555.4M FY10: 485.6M FY11: 638.1M FY12: 683.6M FY13: 714.5M FY14: 719.9M FY15: 993.7M FY16: 1.3B FY17: 1.3B FY18: 1.4B FY19: 1.5B FY20: 1.6B FY21: 2.7B FY22: 3.5B FY23: 2.5B FY24: 2.1B FY25: 2B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 250M 500M 750M FY09: 98.7M FY10: 8.1M FY11: 19.3M FY12: 58.4M FY13: 60.2M FY14: 27.7M FY15: 56.3M FY16: 133.9M FY17: 160.5M FY18: 227M FY19: 224.9M FY20: 256.8M FY21: 305.4M FY22: 653.7M FY23: 372.2M FY24: 320.4M FY25: 269.5M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 200M 400M 600M FY09: 94.9M FY10: 3.9M FY11: 14.7M FY12: 52.9M FY13: 51.1M FY14: 8.5M FY15: 29.3M FY16: 112M FY17: 134M FY18: 191.8M FY19: 189.6M FY20: 219.1M FY21: 251.8M FY22: 577.9M FY23: 268.5M FY24: 239.5M FY25: 233.8M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 20M 40M 60M FY09: 32.6M FY10: 34.8M FY11: 46M FY12: 46.7M FY13: 47.8M FY14: 48.1M FY15: 48.8M FY16: 49.3M FY17: 49.4M FY18: 48.7M FY19: 47.6M FY20: 47.7M FY21: 48M FY22: 44.9M FY23: 39.3M FY24: 38.2M FY25: 38.5M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-8.00 -4.00 0.00 4.00 8.00 12.00 Q4 '10: -1.49 Q1 '11: -1.40 Q2 '11: -1.38 Q3 '11: -0.49 Q4 '11: -0.57 Q1 '12: -0.53 Q2 '12: -0.55 Q3 '12: 0.16 Q4 '12: 0.36 Q1 '13: 0.43 Q2 '13: 0.61 Q3 '13: 0.67 Q4 '13: 0.69 Q1 '14: 0.69 Q2 '14: 0.66 Q3 '14: 0.66 Q4 '14: 0.69 Q1 '15: 0.78 Q2 '15: 0.95 Q3 '15: 1.46 Q4 '15: 1.67 Q1 '16: 1.95 Q2 '16: 2.16 Q3 '16: 2.02 Q4 '16: 2.15 Q1 '17: 2.27 Q2 '17: 2.37 Q3 '17: 2.39 Q4 '17: 2.69 Q1 '18: 2.91 Q2 '18: 3.01 Q3 '18: 3.02 Q4 '18: 2.92 Q1 '19: 2.76 Q2 '19: 2.64 Q3 '19: 2.55 Q4 '19: 2.39 Q1 '20: 1.95 Q2 '20: 1.81 Q3 '20: 1.87 Q4 '20: 1.48 Q1 '21: 2.68 Q2 '21: 3.60 Q3 '21: 4.59 Q4 '21: 6.81 Q1 '22: 8.43 Q2 '22: 9.81 Q3 '22: 10.37 Q4 '22: 9.87 Q1 '23: 8.80 Q2 '23: 7.58 Q3 '23: 6.87 Q4 '23: 5.33 Q1 '24: 3.76 Q2 '24: 2.63 Q3 '24: 1.42 Q4 '24: -3.86 Q1 '25: -4.34 Q2 '25: -7.78 Q3 '25: -7.20 Q4 '25: -2.48 Q1 '26: -0.86 Q2 '26: 2.69 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.